|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 |
| (11) | Number of the document | 2601529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11749629.9 |
| Date of filing the European patent application | 2011-08-05 | |
| (97) | Date of publication of the European application | 2013-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/046799 |
| Date | 2011-08-05 |
| (87) | Number | WO 2012/019125 |
| Date | 2012-02-09 |
| (30) | Number | Date | Country code |
| 201161443955 P | 2011-02-17 | US | |
| 371537 P | 2010-08-06 | US |
| (72) |
GILDERSLEEVE, Jeffrey, US
CAMPBELL, Christopher, US
OYELARAN, Oyindasola, US
GULLEY, James, US
SCHLOM, Jeffrey, US
|
| (73) |
The United States of America, as represented by The Secretary, Department of Health and Human Services,
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, Maryland 20892-7660,
US
|
| (54) | BIOMARKERS FOR PREDICTING RESPONSE TO A CANCER VACCINE |
| BIOMARKERS FOR PREDICTING RESPONSE TO A CANCER VACCINE |